DRUG

Bright Minds Biosciences
DRUG

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$146
62% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Patrick Trucchio
75% 1-yr DRUG win rate
4 Mar ‘26 1 month ago
BTIG
BTIG
Thomas Shrader
50% 1-yr DRUG win rate
17 Feb ‘26 2 months ago